Skip to content

Comparing Rabies Vaccine Schedules: A Study on Two Different Pre-Exposure Methods

Comparative Analysis of Pre-Exposure Prophylaxis (PrEP) Schedules for Rabies Vaccination : A Randomized Non-Inferiority Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075093
Enrollment
60
Registered
2024-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Single visit 4 site Pre-Exposure Prophylaxis.: This group will receive single visit 4 dose of anti-rabies vaccine at a dose of 0.1ml on each deltoid and each supraclavicular region. Co

Sponsors

AMAN DEV SINGH
Lead Sponsor
Rohit Batish
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Immunologically naive healthy human volunteers who have never received anti-rabies treatment in the past and are willing to give verbal consent will be included in study.

Exclusion criteria

Exclusion criteria: Those who have received anti-rabies treatment in the past whether complete or incomplete will be excluded from study.

Design outcomes

Primary

MeasureTime frame
analysis of rabies antibody Titre on day 28th by ELISA method for in both groups and comparison of differences in antibody titre if any.Timepoint: analysis of rabies antibody Titre on day 28th by ELISA method for in both groups and comparison of differences in antibody titre if any.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactAMAN DEV SINGH

Government Medical College and Rajindra Hospital Patiala

adsingh44rssb@gmail.com7837809884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026